One diagnosis. Different tumours.

Oncology · review based on tumour findings

Finding the right doctor in Germany to see your case.

IIMI Institute Message on WhatsApp

Which doctor you need depends on the tumour’s type, stage and characteristics.

07 · GENE

One gene up close

The ERBB2 gene encodes the HER2 protein.

ERBB2 · 17q12

06 · DNA

Tumour DNA

Here the tests look for alterations that matter for the doctor’s decision.

05 · PROTEINS

Tumour proteins

Immunohistochemistry shows the ER and PR receptors and the HER2 protein.

HER2: cell membranes stained

04 · CELLS

Cells up close

At high magnification, the structure of the cells is visible.

03 · TISSUE

Tissue under the microscope

A section from the biopsy shows the tumour type.

02 · IMAGING

The image shows where the lesion is

From the image, the doctor sees the location and size of the lesion.

01 · ORGAN

Inside the breast

Breast cancer most often starts in the ducts.

ONCOLOGY · REVIEW BASED ON TUMOUR FINDINGS

Finding the right doctor in Germany to see your case.

Message on WhatsApp → →

Your situation

Which of these applies to you?

Select your situation: a short video and what you will receive.

  • Oncology You have a diagnosis. Which doctor should see the case?
  • Surgery proposed Is it needed now?
  • Diagnosis in doubt Reports disagree or there is no answer
  • Treatment not helping Treatment has gone on for a long time without improvement
  • Second opinion You have a report and a plan and need an outside view

    • How it works

    Four steps from your message to the doctor’s answer

    You can stop at any step. Your treating doctor remains your doctor.

    04 Doctor’s answer

    The doctor’s written answer. The decision rests with you and your treating doctor.

    03 Finding a doctor

    A doctor of the right specialty at a German hospital reviews your case.

    02 Documents

    After consent: photos of your documents, CT and MRI images on a disc or via a link.

    01 Message

    Write in your own words. No documents are needed yet.

  • specialist
  • what to check
  • written answer
  • next step

    • Worked example

    Breast cancer: what the report shows

    example Where: breast

    Histology and immunohistochemistry · example

  • 1 AI HER2 2+: equivocal result
  • 2 AI ISH is needed for a decision and is not in the documents

    • Example. Not a real patient; the documents contain no personal data.

  • 1 Data
  • 2 Review
  • 3 Doctor
  • 4 Doctor’s answer

    • Data

  • Mammography images
  • Histology pathology report
  • IHC ER, PR, HER2, Ki-67

    • After you consent to the transfer to Germany. Documents can be photographed; CT and MRI images are needed on a disc or via a link.

    Review AI

  • Documents by date
  • Checked against ASCO/CAP
  • Missing: ISH for HER2
  • 1HER2 2+: equivocal result
  • 2ISH is needed for a decision and is not in the documents

    • Only the doctor sees the AI analysis. The doctor makes the diagnosis.

    Doctor Doctor

    Breast oncologist, example University hospital. Reviews the images personally

    The IIMI Institute finds a doctor matched to the case.

    Doctor’s answer · example

    Finding
    HER2 2+: equivocal result
    What to check
    ISH for HER2 (ASCO/CAP)
    What happens next
    The doctor’s written answer. The decision rests with you and your doctor.
    Hello. I have breast cancer. I would like to understand which doctor in Germany should see my case. Send on WhatsApp Write about your situation

    Similar to your case? You can start with a single message.

    Write about your case

    Hello. My wife has breast cancer, and the report says HER2 2+. We have the histology and an MRI. What can be done?

    Hello. Once you have consented to the transfer of your data to Germany, please send the histology report with IHC and the discharge summary.

    Sending now.

  • PDF Histology_IHC.pdf
  • PDF Breast_MRI.zip
  • PDF Discharge_summary.pdf
  • PDFHistology_IHC.pdf
  • PDFBreast_MRI.zip
  • PDFDischarge_summary.pdf

    • Report · example

    Histology and immunohistochemistry report

    Diagnosis
    Invasive carcinoma NST, G2
    Oestrogen receptor (ER)
    90% of nuclei
    Progesterone receptor (PR)
    40% of nuclei
    HER2
    2+ (equivocal)
    Ki-67
    25%

    Example: illustrative data, not a real patient.

    Tumour profile

    Subtype after ISH: HR+/HER2+, luminal B

    Discussion · example

  • Oncologist
  • Pathologist
  • Radiologist

    • Written answer · example

    Doctor’s answer based on your data

    HR+ / HER2+ by ISH, Ki-67 25%

    TNM staging data: tumour size, lymph nodes, CT if needed

    Your questions about the treatment plan, point by point

    The decision rests with you and your doctor.

    What you will receive · example, breast cancer

    What AI does and what the doctor decides

    06 Written answer doctor and you

    What is known, what to check, what to discuss with your doctor.

    05 Discussion doctors

    Doctors of the relevant specialties discuss the case.

    04 Profile AI and doctor

    AI gathers the results into a tumour profile; a doctor checks it.

    03 Review AI and doctor

    The oncologist receives the documents and the AI analysis and notes what is missing for a decision.

    02 Documents You

    After you give consent, files go straight into the chat; documents can be photographed.

    01 Message You

    In your own words, whenever it suits you. No documents are needed yet.

    Start with one message

    Documents later, and only with your consent.

    Honest about limits

    What the IIMI Institute does not promise

  • A cure No one can promise that.

    • No one can promise that.

  • A diagnosis from AI A doctor makes the diagnosis.

    • A doctor makes the diagnosis.

  • A replacement for your doctor You can show the doctor’s answer to your own doctor.

    • You can show the doctor’s answer to your own doctor.

  • Names without consent You learn the doctor’s name after the contract and a confidentiality agreement.

    • You learn the doctor’s name after the contract and a confidentiality agreement.

    Cost

    It depends on the scope of the review. You receive a written estimate before work begins; payment is by bank transfer.

    Questions families ask

    Do I need to travel to Germany?

    You do not need to travel for your documents to be reviewed. A trip is only needed if the doctor suggests an in-person appointment and you decide to come.

    Can I write on behalf of someone close to me?

    Yes. Mention in your message that you are writing on behalf of someone close to you. Their documents are shared with their consent or that of their legal representative.

    Which language should I write in?

    In Russian, English or German. Documents in other languages are fine too: they are translated for the doctor with the help of AI, and a person checks the translation.

    When are documents needed?

    After you consent to your data being transferred to Germany: reports, discharge summaries, images and their written reports, test results. You do not have to send everything at once.

    Who sees my documents?

    Only those who work on your case, and only after your consent. Documents can be deleted at your request, except those a doctor is required by law to keep.

    Who replies on WhatsApp?

    The IIMI Institute replies with the help of AI. A member of staff checks every reply before it is sent.

    When will the doctor answer?

    Usually within 2 to 5 days, depending on the case.

    When are WhatsApp messages answered?

    From 8:00 to 18:00, Munich time.

    Question not listed? Send a message →

    First contact

    Getting to know you starts with one message

    What is your question about?

  • Oncology
  • Surgery proposed
  • Diagnosis in doubt
  • Treatment not helping
  • Second opinion

    • IIMI Institute, a brand of Junisa GmbH Arabellastraße 5, 81925 München

  • WhatsApp +49 176 1014 7020
    • WhatsApp +49 176 1014 7020
  • info@iimi-institute.com
    • info@iimi-institute.com
  • Impressum
    • Impressum
  • Datenschutz
    • Datenschutz

    The body, organs and figures on this page are AI-generated illustrations, labelled where they appear. Images and slides come from open archives; authors and licences are listed below. This page does not replace a consultation with a doctor.

    Sources and licences
  • Body and organs: AI-generated illustration (Higgsfield, GPT Image 2.5); anatomy checked against the Human Reference Atlas, CC BY 4.0.
  • Mammography: National Cancer Institute, Visuals Online, public domain.
  • Chest CT: S. Oka, K. Ono, K. Kajiyama, K. Yoshimatsu, Wikimedia Commons, CC BY-SA 4.0; the authors’ arrow and letters removed.
  • Breast cancer tissue, H&E, two magnifications of one slide: M. Häggström, Wikimedia Commons, CC0.
  • Lung adenocarcinoma, H&E, five magnifications of one slide: Nephron, Wikimedia Commons, CC BY-SA 3.0.
  • Genome diagram: gene coordinates from Ensembl, assembly GRCh38.
  • Lumbar spine MRI, sagittal slice 6 of 12: Stillwaterising, Wikimedia Commons, CC0; scanner annotations removed.
  • Brain MRI, axial slice: Afiller, Wikimedia Commons, CC BY-SA 3.0; scale bar cropped.
  • Body regions, the seated figure, the figure with a phone and the CT: illustrations, AI-generated (Higgsfield, GPT Image 2.5).
  • HER2 2+ requires ISH: Wolff AC et al., ASCO/CAP, J Clin Oncol 2023;41:3867-3872.
  • Biomarkers: Hendriks LE et al., ESMO, Ann Oncol 2023;34:339-357 (lung); Cervantes A et al., ESMO, Ann Oncol 2023;34:10-32 (colorectal); Parker C et al., ESMO, Ann Oncol 2020;31:1119-1134 and EAU 2024 (prostate).
  • Fly-through, brain: pre-operative MRI, Ars Neurochirurgica, Wikimedia Commons, CC BY 4.0 (left half cropped out); glioblastoma sections, Nephron, Wikimedia Commons, CC BY-SA 3.0 (magnifications aligned and rotated).
  • Fly-through, bones: X-ray of an osteosarcoma of the tibia, Yousef Samir, Wikimedia Commons, CC BY-SA 4.0 (cropped); osteosarcoma sections, Nephron, Wikimedia Commons, CC BY-SA 3.0.
  • Fly-through, skin: melanoma photo, National Cancer Institute, public domain; melanoma in situ sections, Nephron, Wikimedia Commons, CC BY-SA 3.0.
  • Fly-through, blood: blood smear in acute myeloid leukaemia, Makysm, Wikimedia Commons, CC0.
  • Fly-through, pancreas: abdominal CT, Hellerhoff, Wikimedia Commons, CC BY-SA 3.0; section of a ductal adenocarcinoma, Singh PK et al., Wikimedia Commons, CC BY 4.0.
  • Organs from the inside (brain, bone, bone marrow, pancreas, skin) and the cells for ‘Other diagnosis’: illustrations, AI-generated (Higgsfield, GPT Image 2.5).
  • Markers for the new diagnoses: Louis DN et al., WHO 2021, Neuro-Oncology 2021 (IDH); Döhner H et al., ELN 2022, Blood 2022 (FLT3, NPM1); ESMO, clinical guidelines on melanoma, 2025 (BRAF); TCGA, Cancer Cell 2017 (KRAS, pancreas); Chen X et al., Cell Reports 2014 (TP53 in osteosarcoma).
  • Work-up in the examples: Conroy T et al., ESMO, Ann Oncol 2023;34:987-1002 (pancreas: BRCA, MSI); Strauss SJ et al., ESMO, Ann Oncol 2021;32:1520-1536 (MRI of the whole bone and chest CT); Weller M et al., EANO, Nat Rev Clin Oncol 2021;18:170-186 (MGMT methylation); AJCC, 8th edition (melanoma staging); The Cancer Genome Atlas Network, Nature 2012;487:330-337 (KRAS, colon).

    • Last updated: 22.10.2026, 23:12 (Munich, CEST)

    WhatsApp

    English Русский Deutsch